aod9604 uses side effects AOD-9604 - Peptide for Fat Loss & Body Composition AOD-9604 vs MOTS-c vs Tesamorelin

The KruskalWallis test was used to evaluate differences in gross morphological scores, histopathological scores, and lameness duration across all four treatment groups

At the end of the study, final blood samples were taken, and the animals were euthanized by cardiac injection

Researchers originally developed this compound as a modified fragment of human growth hormone (HGH) to target fat metabolism without causing many of the hormonal side effects associated with full growth hormone therapy

The trials tested oral, intravenous, and subcutaneous routes of administration at doses ranging from micrograms to 1 mg per day

Potential effects on reproductive health with chronic use are unstudied